January 8, 2018 / 1:19 PM / 10 days ago

BRIEF-Syros Announces 2018 Strategic Priorities And Expected Milestones

Jan 8 (Reuters) - Syros Pharmaceuticals Inc:

* SYROS ANNOUNCES 2018 STRATEGIC PRIORITIES AND EXPECTED MILESTONES

* ON TRACK TO REPORT CLINICAL DATA ON SY-1425 COMBINATIONS AND SY-1365

* CO HAD ABOUT $81.9 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF SEPT 30, 2017

* EXPECTS TO BE ABLE TO FUND ANTICIPATED OPERATING EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below